Novo Nordisk's Rally Has Room To Run Driven By Oral Wegovy's Momentum

🇺🇸 Seeking Alpha (US) —
Novo Nordisk's Rally Has Room To Run Driven By Oral Wegovy's Momentum

AI Summary

Novo Nordisk's stock rally is fueled by the strong sales momentum of its oral obesity drug, Wegovy. Market analysts see further growth potential driven by the product's continued success.

Markets Health Novo Nordisk Wegovy stock rally oral drug obesity treatment

Read original source →